Atlas One · Host Biology · Scale 03 — Molecular

LRRK2

LRRK2 encodes a dual GTPase-kinase; G2019S (most common pathogenic variant) hyperactivates LRRK2 kinase → Rab GTPase hyperphosphorylation → autophagy and vesicle trafficking dysfunction → α-synuclein accumulation; LRRK2 inhibitors are in Phase 2 trials for Parkinson disease.

Also known as: LRRK2, leucine-rich repeat kinase 2, PARK8, dardarin, LRRK2 G2019S, LRRK2 kinase, LRRK2 Parkinson, LRRK2 inhibitor, ROCO protein, LRRK2 GTPase

Scale 03 — MolecularScale
draftStatus
2026-06-07Last Reviewed
This is an auto-generated stub page built from atlas entry frontmatter. A richer hand-crafted page is planned. See the atlas source for the full entry including detailed body sections.
lrrk2

LRRK2

LRRK2 encodes a dual GTPase-kinase; G2019S (most common pathogenic variant) hyperactivates LRRK2 kinase → Rab GTPase hyperphosphorylation → autophagy and vesicle trafficking dysfunction → α-synuclein accumulation; LRRK2 inhibitors are in Phase 2 trials for Parkinson disease.